Synthesis and Evaluation of a 3,4‐dihydro‐2H‐benzoxazine Derivative as a Potent CDK9 Inhibitor for Anticancer Therapy.
- Published in:
- Bulletin of the Korean Chemical Society, 2021, v. 42, n. 3, p. 416, doi. 10.1002/bkcs.12204
- By:
- Publication type:
- Article